Company · founded 1998
Ingenious Targeting Laboratory (United States)
Ronkonkoma, United States · genetargeting.com
- Citations, last 5 years
- 5
- Works, last 5 years
- 7
- h-index
- 23
- Scientists listed
- 0
- Grants since 2016
- 9
Grants received
2021–2022 · research · R43
Humanization of ACE2 and Associated Priming Proteases in New Mouse Models for Downstream Disease and Therapy Investigations of COVID-19
Wei Weng · Ingenious Targeting Laboratory (United States) · funded by National Institutes of Health
2021–2022 · research · R43
Humanization of ACE2 and Associated Priming Proteases in New Mouse Models for Downstream Disease and Therapy Investigations of COVID-19
Wei Weng · Ingenious Targeting Laboratory (United States) · funded by National Institutes of Health
2019–2021 · research · R43
Genetic Modification of the Rabbit for Development of Single Chain Antibodies
Thomas Zeyda · Ingenious Targeting Laboratory (United States) · funded by National Institutes of Health
2018–2020 · research · R43
A Novel Small Animal Model as a Source of Therapy-Bound Single-Chain Antibody Products
Milen Kirilov · Ingenious Targeting Laboratory (United States) · funded by National Institutes of Health
2018–2025 · research · R44
Research and Development to Establish a Small Animal Model as a Significant Resource of High-Value Single-Domain Antibodies
Milen Kirilov · Ingenious Targeting Laboratory (United States) · funded by National Institutes of Health
2018–2025 · research · R44
Research and Development to Establish a Small Animal Model as a Significant Resource of High-Value Single-Domain Antibodies
Milen Kirilov · Ingenious Targeting Laboratory (United States) · funded by National Institutes of Health
2018–2021 · research · R43
A Novel Small Animal Model as a Source of Therapy-Bound Single-Chain Antibody Products
Milen Kirilov · Ingenious Targeting Laboratory (United States) · funded by National Institutes of Health
2018–2025 · research · R44
Research and Development to Establish a Small Animal Model as a Significant Resource of High-Value Single-Domain Antibodies
Milen Kirilov · Ingenious Targeting Laboratory (United States) · funded by National Institutes of Health
2018–2021 · research · R43
Business Potential of a Novel Small Animal Model and its Single-Chain Antibodies
Milen Kirilov · Ingenious Targeting Laboratory (United States) · funded by National Institutes of Health